Data Panel Acquisition Corp.

Private Company, Headquarters Location
7313 Washington Ave. S, Minneapolis, MN 55439, United States
(952)941-3511, (952)941-3931 fax, http://www.datapanel.com

Primary SIC: Relays & Industrial Controls, Primary NAICS: Relay and Industrial Control Manufacturing
Description: Manufacturing: Manufactures electronic applications switches; manufactures signs and advertising specialties; manufactures computer and office machine keyboards

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Data Panel Acquisition Corp., News and Information

Optical Cable Corporation Acquires Applied Optical Systems, Inc.
Biotech Week; 11/18/2009; 1300 words; ...applications. The acquisition was completed on...optic and copper data communications cabling...enclosures, patch panels, face plates, multi...acquisition of SMP Data Communications in...copper connectivity data communications standards...Gas, Optical Cable Corp, ...

Bank officials to testify Nov. 17 ; House panel moved hearing on Merrill deal to gather data
The Boston Globe; 11/6/2009; 721 words; ...America's $50 billion acquisition of troubled investment bank...misleading shareholders about the acquisition by failing to disclose the...New England, CVS Caremark Corp. CEO Thomas Ryan, are on the six-member panel that will select the company...

Other News To Note.
BIOWORLD Today; 11/4/2009; 1465 words; ...technology of IBM Corp., of Armonk, N...augment its internal data mining system with...Crucell identified a panel of fully human monoclonal...LCH models. CytRx Corp., of Los Angeles...glioma. Neurogen Corp., of Branford...investment in, or acquisition of, complementary...

Alternative Financings Provide Biotechs With More Options.
BIOWORLD Today; 11/3/2009; 1561 words; ...alternatives last week in a panel organized by the...Dynavax Technologies Corp. and Alexza Pharmaceuticals...different take on asset acquisition as a nondilutive...revenues. And when Dyax Corp. needed flexibility...request for more data on DX-88 in hereditary...like Drug Royalty ...

Investors Discuss Funding Options In Difficult Market.
BIOWORLD Today; 11/3/2009; 1225 words; ...investors said during a panel discussion at the...Aspreva Pharmaceuticals Corp. to a $17.25...consider merger or acquisition opportunities; however...acquire. Genzyme Corp., of Cambridge...is closed and an acquisition doesn't seem likely...Investors want clinical data, experienced ...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.